Tech Company Financing Transactions
Sequel Pharmaceuticals Funding Round
Sequel Pharmaceuticals, based in San Diego, raised $1.4 million from private investors.
Transaction Overview
Company Name
Announced On
9/7/2010
Transaction Type
Debt
Amount
$1,367,579
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12790 El Camino Real 300
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Sequel Pharmaceuticals is a privately held product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing novel clinical-stage drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randall Woods
Browse more venture capital transactions:
Prev: 9/7/2010: OhMyGov venture capital transaction
Next: 9/7/2010: Amedica venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs